Page last updated: 2024-10-29

staurosporine aglycone and Bone Fractures

staurosporine aglycone has been researched along with Bone Fractures in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Research Excerpts

ExcerptRelevanceReference
"Mechanical hyperalgesia continued for 28 days at a lesion in the BLG, 21 days in PLG and 5 days in SLG after treatments, respectively."1.38Nerve growth factor and associated nerve sprouting contribute to local mechanical hyperalgesia in a rat model of bone injury. ( Hayashi, K; Hori, K; Ichiyanagi, M; Ozaki, N; Shiraishi, Y; Sugiura, Y; Yasui, M, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yasui, M1
Shiraishi, Y1
Ozaki, N1
Hayashi, K1
Hori, K1
Ichiyanagi, M1
Sugiura, Y1

Other Studies

1 other study available for staurosporine aglycone and Bone Fractures

ArticleYear
Nerve growth factor and associated nerve sprouting contribute to local mechanical hyperalgesia in a rat model of bone injury.
    European journal of pain (London, England), 2012, Volume: 16, Issue:7

    Topics: Animals; Antibodies, Neutralizing; Behavior, Animal; Bone and Bones; Carbazoles; Disease Models, Ani

2012